AstraZeneca Nasal Spray Vaccine For Covid Fizzles In Small, Early Trial
AstraZeneca Plc’s nasal spray vaccine failed to elicit a strong immune response to Covid-19 in an early trial, a blow to the UK drug giant’s ambitions for developing an alternative approach to preventing the disease.
The spray vaccine…
Read More...
Read More...